Literature DB >> 17899166

Subtype-selective blockade of cardiac muscarinic receptors inhibits vagal chronotropic responses in cats.

Oleg E Osadchii1.   

Abstract

This study was designed to determine if chronotropic responses induced by neurally released acetylcholine are modified by subtype-selective blockade of cardiac muscarinic cholinoreceptors. In anesthetized cats, a single burst of vagal stimulation was generated with an incremental time delay after the P wave of the atrial electrogram (P-Stimulus interval). The slope of the relationships between P-Stimulus and P-P intervals was used to assess changes in responsiveness of cardiac pacemaker to vagal effects throughout the cardiac cycle. An increase in P-Stimulus interval over the initial portion (approximately 120 ms) of the cardiac cycle produced a significant increment in lengthening of the P-P interval. Once the maximal negative chronotropic response was achieved, a further increase in P-Stimulus interval by only approximately 25 ms resulted in profound (by 80-90%) reductions in vagal effects, thus yielding a bimodal vagal phase response curve. Antagonists of M1 (pirenzepine), M2 (methoctramine and gallamine), and M3 (4-DAMP) muscarinic cholinoreceptors produced a reduction in the magnitude of maximal lengthening of cardiac cycle as well as an increase in latency of vagal effects. However, the increment in prolongation of P-P interval induced by a given change in timing of vagal stimulation during cardiac cycle was reduced by M1 and M2 muscarinic receptor blockers, but was unaffected by 4-DAMP. None of the antagonists modified the range of P-Stimulus intervals over which the maximum-to-minimum change of vagal responses occurred. Taken together, these data suggest different contribution of various subtypes of cardiac muscarinic receptors into the negative chronotropic responses induced by brief bursts of vagal stimulation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17899166     DOI: 10.1007/s00424-007-0347-7

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  45 in total

1.  Expression of multiple subtypes of muscarinic receptors and cellular distribution in the human heart.

Authors:  H Wang; H Han; L Zhang; H Shi; G Schram; S Nattel; Z Wang
Journal:  Mol Pharmacol       Date:  2001-05       Impact factor: 4.436

Review 2.  Functional M3 muscarinic acetylcholine receptors in mammalian hearts.

Authors:  Zhiguo Wang; Hong Shi; Huizhen Wang
Journal:  Br J Pharmacol       Date:  2004-05-17       Impact factor: 8.739

3.  Effects of the spatial dispersion of acetylcholine release on the chronotropic responses to vagal stimulation in dogs.

Authors:  T E Yang; J Cheng; M N Levy
Journal:  Circ Res       Date:  1990-10       Impact factor: 17.367

Review 4.  International Union of Pharmacology. XVII. Classification of muscarinic acetylcholine receptors.

Authors:  M P Caulfield; N J Birdsall
Journal:  Pharmacol Rev       Date:  1998-06       Impact factor: 25.468

Review 5.  Parasympathetic control of the heart.

Authors:  C B Higgins; S F Vatner; E Braunwald
Journal:  Pharmacol Rev       Date:  1973-03       Impact factor: 25.468

6.  Effects of ionic channel antagonists barium, cesium, and UL-FS-49 on vagal slowing of atrial rate in dogs.

Authors:  D W Wallick; A Kuguoglu; T Yang; S L Stuesse; M N Levy
Journal:  Am J Physiol       Date:  1997-11

7.  Dynamic vagal control of pacemaker activity in the mammalian sinoatrial node.

Authors:  J Jalife; V A Slenter; J J Salata; D C Michaels
Journal:  Circ Res       Date:  1983-06       Impact factor: 17.367

8.  Neural regulation of slow-wave frequency in the murine gastric antrum.

Authors:  Abigail S Forrest; Tamás Ordög; Kenton M Sanders
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2005-09-15       Impact factor: 4.052

9.  Pirenzepine distinguishes between different subclasses of muscarinic receptors.

Authors:  R Hammer; C P Berrie; N J Birdsall; A S Burgen; E C Hulme
Journal:  Nature       Date:  1980-01-03       Impact factor: 49.962

10.  Antimuscarinic action of methoctramine, a new cardioselective M-2 muscarinic receptor antagonist, alone and in combination with atropine and gallamine.

Authors:  C Melchiorre; P Angeli; G Lambrecht; E Mutschler; M T Picchio; J Wess
Journal:  Eur J Pharmacol       Date:  1987-12-01       Impact factor: 4.432

View more
  1 in total

1.  Targeted G-protein inhibition as a novel approach to decrease vagal atrial fibrillation by selective parasympathetic attenuation.

Authors:  Gary L Aistrup; Roger Villuendas; Jason Ng; Annette Gilchrist; Thomas W Lynch; David Gordon; Ivan Cokic; Steven Mottl; Rui Zhou; David A Dean; J Andrew Wasserstrom; Jeffrey J Goldberger; Alan H Kadish; Rishi Arora
Journal:  Cardiovasc Res       Date:  2009-05-20       Impact factor: 10.787

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.